Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: AVO

American BioDefense Institute Commends Congressman Gosar for BioSecurity Amendment

WASHINGTON, July 15, 2020 /PRNewswire/ -- On behalf of the American BioDefense Institute, we commend Rep. Paul Gosar of Arizona on proposing an amendment to the H.R.6395 - William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021. We submit this statement for the record to urge Congress to include this amendment into the final bill to provide useful rapid pandemic response capabilities.

This amendment would add the Pandemic Prevention Platform to H.R.6395, obliging the Secretary of Defense to establish a program "to implement and advance the development of rapid and cost-effective medical countermeasures to pandemics." The objective is to ensure that our nation has the capability to respond to any pandemic within 60 days of identifying a virus or other pathogen and make every effort to reduce this time frame to 28 days. This would provide unprecedented capabilities to contain and suppress any pandemic before it spreads.

This initiative addresses a bipartisan issue. The development of rapid pandemic response tools is a vital national security issue and a public health issue. Congressman Gosar has rightly recognized that pandemic prevention is a vital issue that has not been appropriately recognized until now. Given the current COVID-19 pandemic and its broader economic and social consequences, it is necessary to take action to prevent any future pandemic from having a similar effect.

One of the vital provisions of the amendment is the challenge to the American ingenuity to reduce the time frame of the rapid pandemic response from 60 days to 28 days. In the first 60 days of a pandemic, every day is crucial, and being able to deploy pandemic countermeasures as early as possible is vital in saving lives. This amendment recognizes the importance of this and also recognizes that American companies and research institutions are capable of developing cutting-edge pandemic response tools with the U.S. government's support.

The development of rapid pandemic response tools holds the promise of effectively countering any future emerging infectious disease at its source. By preventing its spread worldwide and containing it and eradicating it if it reaches the U.S. These tools can be used both as a therapy for the infected patients and as a passive immunization method to prevent further infections and spread of the disease.

The American BioDefense Institute urges Congress to accept this amendment to the H.R.6395 - William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021. And ensure that the U.S. healthcare system is equipped to deal with any future pandemic effectively and that the American people are given the pandemic protection they deserve. The ongoing COVID-19 pandemic has shown that this is a vital issue of both national security and public health, and a necessary measure to protect the U.S. economy and the American way of life.

For more information contact Neilfoote@ascendantgroupbranding.com, 214.448.3765

Related Images

American Bio Defense Institute

SOURCE American BioDefense Institute

These press releases may also interest you

at 10:25
CrowdStrike Inc., a leader in cloud-delivered endpoint and workload protection, today announced it has been named a Leader in The Forrester Wavetm: Endpoint Security Software As A Service, Q2 20211. CrowdStrike also received the highest scores...

at 10:25
A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Industrial Brakes and Clutches - Global Market Trajectory & Analytics". The report presents fresh perspectives...

at 10:21
FXT, a blockchain-based trading technology platform that successfully completed the ICO of its FXT token for global investors, recorded a whopping 1,500% increase in its token price in the first half of May....

at 10:20
3Play Media, the leading video accessibility provider, announced today the addition of two new members to its Board of Directors. David Mendels, former CEO and President of Brightcove, and Frances West, former Chief Accessibility Officer at IBM,...

at 10:20
Integrated Specialty Coverages ("ISC"), a leading, multi-line program administrator that builds end-to-end insurance products utilizing artificial intelligence (AI) technology and analytics, today announced the launch of a unique new General...

at 10:20
Code42, the Insider Risk Management leader, today announced that it has enhanced its Incydrtm data risk detection and response product with a prioritized view of the highest-risk data exposure and exfiltration events happening across organizations....

News published on 15 july 2020 at 19:32 and distributed by: